ArticlePhotochemistry and photobiology
Collagen-derived hydroxyproline-containing cyclic dipeptides prevent photoaging-related inflammatory response in UVB-irradiated epidermal keratinocytes.
Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species (ROS) are major contributors to skin photoaging, which is cumulatively caused by sunlight exposure. We previously developed a unique collagen hydrolysate, named H-GDCH, enriched with hydroxyproline (Hyp)-containing cyclic dipeptides, cyclo(X-Hyp), using ginger protease and subsequent heat treatment. Here, we demonstrated the inhibitory effects of cyclo(X-Hyp) and H-GDCH on ultraviolet B (UVB)-induced photoaging-related inflammatory response in normal human epidermal keratinocytes (NHEK). Cyclo(X-Hyp) significantly decreased intracellular ROS generated by UVB irradiation. The ROS scavenging ability of cyclo(X-Hyp) was superior to that of the corresponding linear dipeptides (X-Hyp) and Pro-containing cyclic dipeptides [cyclo(X-Pro)], respectively. Cyclo(X-Hyp) suppressed ROS-induced activation of inflammatory pathways, including nuclear factor-κB and mitogen-activated protein kinases, and the subsequent increase in matrix metalloproteinase (MMP)-2/MMP-9; moreover, it inhibited the reduction of type IV collagen. ROS production and the downstream events simulated by UVB were also prevented by culturing with H-GDCH. Cyclo(X-Hyp) penetrated human dermatomed skin with high efficiency, reaching 10% after a 24-h incubation. These results indicate that cyclo(X-Hyp) and the cyclo(X-Hyp)-rich collagen hydrolysate, H-GDCH, have the potential as anti-photoaging agents in skin health applications, including cosmetics and functional foods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.